{"id":"W4288051973","doi":"10.1002/cncr.34394","title":"A randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: <scp>BilT</scp>‐01","year":2022,"lang":"en","type":"article","venue":"Cancer","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Comprehensive Cancer Center, University of Michigan; Bristol-Myers Squibb Canada; Bristol-Myers Squibb","keywords":"Nivolumab; Medicine; Ipilimumab; Gemcitabine; Oncology; Biliary tract cancer; Internal medicine; Cisplatin; Randomized controlled trial; Cancer; Phases of clinical research; Chemotherapy; Immunotherapy","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002199604,0.002090323,0.001865749,0.0004200523,0.0004227593,0.001098285,0.0008628141,0.001546128,0.008382855],"category_scores_gemma":[0.001949493,0.0007958474,0.00137065,0.0003553231,0.001314468,0.0009322389,0.0004852365,0.002936335,0.001187882],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009635217,"about_ca_system_score_gemma":0.001718348,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001137585,"about_ca_topic_score_gemma":0.002984049,"domain_scores_codex":[0.9991868,0.0005137381,0.00003101707,0.0001338091,0.00004105889,0.00009360868],"domain_scores_gemma":[0.9988575,0.0002668074,0.0002854103,0.00008658977,0.00005326111,0.0004504159],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9801743,0.008043772,0.0006748235,0.0001911825,0.0004102826,0.00003498987,0.00005007047,0.0003377718,0.001745548,0.0001064537,0.000954824,0.007275899],"study_design_scores_gemma":[0.966038,0.03204585,0.0007769709,0.00001343052,0.0001356614,0.00002246321,0.00001383362,0.0003106725,0.0001471468,0.00008888531,0.0003998983,0.000007097806],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9885162,0.001349358,0.0004472149,0.0008545374,0.0005868247,0.00541898,0.0009610181,0.00008653837,0.001779253],"genre_scores_gemma":[0.9787793,0.001488874,0.001864011,0.001807892,0.0005133579,0.009346472,0.001780753,0.00003186594,0.004387489],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008382855,"threshold_uncertainty_score":0.02804345,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02302636326951077,"score_gpt":0.318445493622079,"score_spread":0.2954191303525683,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}